RUC-4 is a novel, potent and non-RGD-mimetic aIIbss3 antagonist with IC50 of 45 nM, with no activity on αVβ3 receptors. It can be used for prehospital therapy of myocardial infarction.

纯度：≥98%

CAS：1448313-27-6